Mr. Singh is Chief Executive Officer of Juniper Biologics, a science-led healthcare company headquartered in Singapore that is researching, developing and commercializing innovative medications in the areas of Oncology, Rare and Orphan Diseases, and Gene Therapy. Prior to his current role, Mr. Singh was Chief Executive Officer of Mundipharma Pte Limited, which is part of a network of independent associated companies active in the fields of respiratory, oncology, pain and biosimilars. He has also served in various commercial roles for multi-national pharmaceutical companies including, vice president of commercial operations for emerging markets at GSK, regional leadership roles in Australia, New Zealand, and Korea for Abbott, as well as various sales, marketing and strategy positions at Bayer. Mr. Singh graduated with a Bachelors in Mechanical Engineering. He also holds Masters of Business Administration from Assumption University and Masters in International Management from Thunderbird School of International Management. He currently serves on the boards of Biofourmis Healthcare and Neuroglee Therapeutics.